review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0895-4356(97)00169-8 |
P698 | PubMed publication ID | 9393381 |
P2093 | author name string | Horwitz RI | |
Richardson ED | |||
Haskell SG | |||
P2860 | cites work | Estrogen use and verbal memory in healthy postmenopausal women. | Q52057737 |
The sex difference on one test of spatial visualization: a nontrivial difference. | Q52098020 | ||
Evaluating storage, retention, and retrieval in disordered memory and learning | Q52115465 | ||
Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. | Q52127221 | ||
Effects of estrogen on memory function in surgically menopausal women | Q52229708 | ||
Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory | Q52243867 | ||
Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974 | Q53304921 | ||
A Standardized Memory Scale for Clinical Use | Q57602240 | ||
The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings | Q57782178 | ||
Further psychometric evaluation of older women--the effect of estrogen administration | Q68614481 | ||
Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study | Q72059302 | ||
The effects of the menstrual cycle on test performance | Q77132367 | ||
A rating scale for depression | Q24564540 | ||
“Mini-mental state” | Q25938989 | ||
Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features | Q34179037 | ||
Hormone therapy to prevent disease and prolong life in postmenopausal women | Q34262585 | ||
Steroid and thyroid hormones modulate a changing brain | Q37544394 | ||
Incidence of severe dementia in an urban sample followed from 70 to 79 years of age | Q39342582 | ||
The prevalence of dementia: a quantitative integration of the literature | Q39692741 | ||
Variations in sex-related cognitive abilities across the menstrual cycle | Q41207707 | ||
In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). | Q41256378 | ||
Changes in cognitive task performance across the menstrual cycle. | Q41637668 | ||
Alteration of muscarinic binding in specific brain areas following estrogen treatment. | Q42468656 | ||
Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood | Q43806632 | ||
Women, myocardial infarction, and dementia in the very old. | Q44824278 | ||
Incidence of Dementia in the Lundby Study | Q44879843 | ||
Lack of postmenopausal estrogen replacement therapy and the risk of dementia | Q44928202 | ||
Epidemiology of clinically diagnosed Alzheimer's disease | Q45268892 | ||
Estrogen deficiency and risk of Alzheimer's disease in women. | Q45935585 | ||
Presenile dementia in Israel | Q46416105 | ||
Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects | Q46604770 | ||
Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type | Q48395222 | ||
Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain | Q48469805 | ||
Sex differences in cholinergic enzymes of diagonal band nuclei in the rat preoptic area | Q48797196 | ||
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease | Q50613976 | ||
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. | Q51183354 | ||
Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. | Q52037686 | ||
P433 | issue | 11 | |
P304 | page(s) | 1249-1264 | |
P577 | publication date | 1997-11-01 | |
P1433 | published in | Journal of Clinical Epidemiology | Q6294959 |
P1476 | title | The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature | |
P478 | volume | 50 |
Q33803356 | "Extracts from "Clinical evidence": Menopausal symptoms |
Q60619053 | Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans |
Q35060342 | Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions |
Q44524327 | Alcohol, estrogen replacement therapy, and visuospatial processes in postmenopausal women |
Q34098884 | An absence of evidence linking perceived memory problems to the menopause. |
Q35053241 | Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease. |
Q35910115 | Benefits and risks of sex hormone replacement in postmenopausal women |
Q34997783 | Brain aging and Alzheimer's disease; use it or lose it. |
Q34037204 | Causes of Alzheimer's disease |
Q43438290 | Chronic administration of tibolone modulates anxiety-like behavior and enhances cognitive performance in ovariectomized rats |
Q36230482 | Contraceptive Use Affects Overall Olfactory Performance: Investigation of Estradiol Dosage and Duration of Intake |
Q34777681 | Dementia epidemiology |
Q33757746 | Effect of SERMs on the uterus and menopausal symptoms |
Q44306076 | Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia |
Q44105495 | Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomologus monkeys |
Q51979651 | Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. |
Q44460326 | Endogenous estrogen formation is neuroprotective in model of cerebellar ataxia |
Q44533516 | Estradiol selectively affects processing of conspecifics' faces in female rhesus monkeys. |
Q35830687 | Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women |
Q43992285 | Estradiol, but not raloxifene, improves aspects of spatial working memory in aged ovariectomized rhesus monkeys. |
Q37076464 | Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial |
Q41681346 | Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women |
Q43850527 | Estrogen replacement therapy: a perspective on cognitive impact |
Q60640524 | Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats |
Q24653773 | Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone |
Q43561568 | Exploration of cyclical changes in memory and mood in postmenopausal women taking sequential combined oestrogen and progestogen preparations |
Q33232047 | Exploring the continuum: medical information to effective clinical practice. Paper I: the translation of knowledge into clinical practice |
Q43638441 | Fluctuations in spatial recognition memory across the menstrual cycle in female rhesus monkeys. |
Q36146996 | Gender, sex steroid hormones, and Alzheimer's disease. |
Q37795699 | Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders |
Q34102629 | Genetics of menopause-associated diseases |
Q43968041 | Gonadal hormones are responsible for maintaining the integrity of spine synapses in the CA1 hippocampal subfield of female nonhuman primates |
Q73179172 | Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy |
Q48206860 | Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging |
Q84420552 | Menopausal symptoms |
Q84478576 | Menopausal symptoms |
Q39428965 | Menopause and hormone replacement |
Q48730265 | Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women |
Q48491933 | Neuroprotection in Alzheimer's disease - new strategies for treatment. |
Q35558569 | Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review |
Q27008086 | Postmenopausal hormone therapy and cognition |
Q89562164 | Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function |
Q31979952 | Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen |
Q34174220 | Preventing dementia |
Q36436653 | Prognostic factors in paediatric anaplastic large cell lymphoma: role of ALK. |
Q37309638 | Protective actions of sex steroid hormones in Alzheimer's disease |
Q48251883 | Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women |
Q34030136 | Raloxifene: a review of its use in postmenopausal osteoporosis |
Q33688768 | Recent developments in the drug treatment of Alzheimer's disease |
Q38427694 | Sex differences in episodic memory: minimal influence of estradiol. |
Q37118735 | Steroids as γ-secretase modulators |
Q52027965 | Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory. |
Q34951934 | The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review |
Q36076993 | The effects of raloxifene treatment on oxidative status in brain tissues and learning process of ovariectomized rats |
Q33873102 | The evolving role of specific estrogen receptor modulators (SERMs) |
Q35134604 | The menopause and HRT. HRT and cognitive decline |
Q40735061 | The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. |
Q33756911 | Theoretical basis for the benefit of postmenopausal estrogen substitution |
Q38448466 | Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels |
Search more.